ES2052579T3 - Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida. - Google Patents

Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.

Info

Publication number
ES2052579T3
ES2052579T3 ES87309312T ES87309312T ES2052579T3 ES 2052579 T3 ES2052579 T3 ES 2052579T3 ES 87309312 T ES87309312 T ES 87309312T ES 87309312 T ES87309312 T ES 87309312T ES 2052579 T3 ES2052579 T3 ES 2052579T3
Authority
ES
Spain
Prior art keywords
manufacture
interferon alpha
human recombinant
medicinal product
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87309312T
Other languages
English (en)
Spanish (es)
Inventor
Judith Feinberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25446188&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2052579(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2052579T3 publication Critical patent/ES2052579T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES87309312T 1986-10-22 1987-10-21 Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida. Expired - Lifetime ES2052579T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92192286A 1986-10-22 1986-10-22

Publications (1)

Publication Number Publication Date
ES2052579T3 true ES2052579T3 (es) 1994-07-16

Family

ID=25446188

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87309312T Expired - Lifetime ES2052579T3 (es) 1986-10-22 1987-10-21 Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.

Country Status (8)

Country Link
EP (1) EP0266940B1 (enExample)
JP (1) JPS63104929A (enExample)
AT (1) ATE83381T1 (enExample)
CA (1) CA1297788C (enExample)
DE (1) DE3783122T2 (enExample)
ES (1) ES2052579T3 (enExample)
GR (1) GR3006999T3 (enExample)
OA (1) OA08768A (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT99837A (pt) * 1990-12-21 1992-12-31 Schering Corp Processo para a preparacao de composicoes farmaceuticas contendo interferao alfa e metodo para administracao de interferao alfa por inalacao oral para tratar asma e doencas pulmonares proliferativas nao malignas
MX9307733A (es) * 1992-12-23 1994-06-30 Schering Corp Restauracion de la funcion inmunologica en pacientes asintomaticos de vih-positivo.
FR2713657B1 (fr) * 1993-12-13 1996-03-01 Transgene Sa Nouveaux vecteurs pour le traitement du sida.
PL2294066T3 (pl) 2008-04-28 2015-02-27 Janssen Pharmaceutica Nv Benzimidazole jako inhibitory hydroksylazy prolilowej
CA2853455C (en) 2011-10-25 2019-12-03 Janssen Pharmaceutica Nv Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
CN112245570A (zh) * 2019-07-22 2021-01-22 厦门特宝生物工程股份有限公司 一种基于干扰素的疾病治疗方法

Also Published As

Publication number Publication date
ATE83381T1 (de) 1993-01-15
GR3006999T3 (enExample) 1993-06-30
JPS63104929A (ja) 1988-05-10
EP0266940A1 (en) 1988-05-11
DE3783122T2 (de) 1993-04-22
OA08768A (fr) 1989-03-31
DE3783122D1 (de) 1993-01-28
CA1297788C (en) 1992-03-24
EP0266940B1 (en) 1992-12-16

Similar Documents

Publication Publication Date Title
FI95653C (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
DK602988A (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
KR890700035A (ko) 개량된 인터페론 요법
ATE94393T1 (de) Dosisform zur oralen verabreichung des hypoglykaemischen glipizids.
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DK486588D0 (da) Konjungater af cytokininer med immunglobuliner
MX9206817A (es) Nuevos azoheterociclilmetil-cromanos, procedimiento para su obtencion y medicamento que los contiene.
ES541103A0 (es) Procedimiento de obtencion de una composicion para el trata-miento de infecciones virales
ES8704170A1 (es) Un procedimiento para preparar derivados de guanina
ES2052579T3 (es) Empleo de interferon alfa humano recombinante para la fabricacion de un medicamento para tratar el virus del sida.
ES8400742A1 (es) Procedimiento de preparacion de las dibenzooxepinas sustituidas y de sus sales de adicion con un acido mineral u organi-co.
ES2036526T3 (es) Composiciones de interferon.
ES2191662T3 (es) Utilizacion de una polihidroxi-benzamida o uno de sus derivados en la fabricacion de un medicamento destinado al tratamiento de infecciones virales.
KR910700069A (ko) Gm-csf를 사용한 백혈구 기능장애의 치료
PT651654E (pt) Utilizacao de um dimero de lisozima para a preparacao de um medicamento para modular os mecanismos natutais de defesa
ES2125879T3 (es) Triazaespirodecanona-metilcromanos para el tratamiento de enfermedades del sistema nervioso central.
ES2148234T3 (es) Composicion farmaceutica a base de flavopereirina y su utilizacion en el tratamiento del virus vih.
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
DE3788899D1 (de) Intraläsionale Behandlung von Basalzellenkarzinoma mittels rekombinanten humanen alpha-Interferons.
UA42693C2 (uk) Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
ATE137968T1 (de) Verwendung von l-2-oxothiazolidine-4-carboxylate zur herstellung eines arzneimittels zur behandlung von latenten hiv-infektionen
ES2042715T3 (es) Remedio medico veterinario y humano que tiene una actividad antivirial y antitumoral que contiene 2,6-diamino-3-fenil-azo-piridina.
AR035767A1 (es) Compuesto de l-ribofuranosil triazol-3-carboxamida modulador de una respuesta inmune y su uso para la fabricacion de un medicamento
DK374388A (da) Immunterapeutisk, oral interferondosisform samt fremgangsmaade til fremstilling heraf
UA31649A (uk) Спосіб лікування захворювань, які викликані тоrсн - інфекціями

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 266940

Country of ref document: ES